TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT05714397 — Predictive Biomarker (PRD): TH mRNA
Genes: TH; TYH
Study NCT05714397 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05937100 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05040464 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05881330 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05174507 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT05993325 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06636591 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05540275 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study NCT05540275 — Predictive Biomarker (PRD): TERT mRNA
Genes: TERT; EST2; TCS1; TRT
Study NCT04761588 — Predictive Biomarker (PRD): TYR mRNA
Genes: TYR
Study NCT05524532 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05287100 — Surrogate Endpoint (SUR): Serum sodium
Study NCT05054582 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT05431179 — Predictive Biomarker (PRD): RORA
Genes: RZRA; ROR1; ROR2; ROR3; NR1F1; ROR-alpha; RORalpha; RORa1
Study NCT03492268 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT05534607 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02493322 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05507203 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04933227 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04933227 — Predictive Biomarker (PRD): TIGIT mRNA
Genes: TIGIT; VSIG9; VSTM3
Study NCT05526911 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT05550896 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT06230835 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00394537 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06695559 — Surrogate Endpoint (SUR): Probing pocket depth
Study NCT06695559 — Monitoring Biomarker (MOI): Matrix metalloproteinase 8
Genes: MMP8; CLG1
Study NCT06132360 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT05860400 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05704829 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05736146 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT06391944 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05487495 — Predictive Biomarker (PRD): CD5 mRNA
Genes: CD5; LEU1
Study NCT02454764 — Monitoring Biomarker (MOI): HBV DNA
Study NCT05984810 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT05955079 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT05414253 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05611424 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT06232226 — Monitoring Biomarker (MOI): Adenosine deaminase
Genes: ADA; ADA1
Study NCT04773808 — Predictive Biomarker (PRD): SH3PXD2A mRNA
Genes: SH3PXD2A; FISH; KIAA0418; SH3MD1; TKS5
Study NCT05511844 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05632029 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05736562 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT06528210 — Predictive Biomarker (PRD): GNRH1 mRNA
Genes: GNRH1; GNRH; GRH; LHRH
Study NCT05820009 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT06479083 — Safety Biomarker (SAF): Aminopeptidase N
Genes: ANPEP; APN; CD13; PEPN
Study NCT04476485 — Predictive Biomarker (PRD): Hormone receptor
Study NCT05154162 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05034887 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05592730 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT05592730 — Predictive Biomarker (PRD): AMHR2 mRNA
Genes: AMHR2; AMHR; MISR2
Study NCT05592730 — Predictive Biomarker (PRD): Hormone receptor
Study NCT05111964 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study NCT05554003 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study NCT05554003 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study NCT06389695 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05586100 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06254690 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05668676 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05668676 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04995003 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04995003 — Predictive Biomarker (PRD): CD28 mRNA
Genes: CD28
Study NCT06260904 — Safety Biomarker (SAF): DHFR
Genes: DHFR1
Study NCT06260904 — Pharmacodynamic Biomarker (PDY): Cyclic adenosine monophosphate
Study NCT05034978 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04965870 — Predictive Biomarker (PRD): TPI1 mRNA
Genes: TPI1; TPI
Study NCT05008458 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study NCT05008458 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT05257213 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05521282 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05521282 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06012695 — Predictive Biomarker (PRD): BMX mRNA
Genes: BMX
Study NCT06012695 — Predictive Biomarker (PRD): HDAC8 mRNA
Genes: HDAC8; HDACL1; CDA07
Study NCT06501261 — Predictive Biomarker (PRD): PICALM mRNA
Genes: PICALM; CALM
Study NCT05236127 — Predictive Biomarker (PRD): GFAP mRNA
Genes: GFAP
Study NCT05534841 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT05679609 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT05907499 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Placenta growth factor
Genes: PGF; PGFL; PLGF
Study NCT05588180 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05284513 — Predictive Biomarker (PRD): FH mRNA
Genes: FH
Study NCT05648214 — Predictive Biomarker (PRD): PNP mRNA
Genes: PNP; NP
Study NCT05648214 — Predictive Biomarker (PRD): PNPLA3 mRNA
Genes: PNPLA3; ADPN; C22orf20
Study NCT06003621 — Predictive Biomarker (PRD): TIGIT mRNA
Genes: TIGIT; VSIG9; VSTM3
Study NCT06563349 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT06563349 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06590558 — Predictive Biomarker (PRD): XIAP mRNA
Genes: XIAP; API3; BIRC4; IAP3
Study NCT05579119 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT06070532 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT06070532 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06070532 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT06070532 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05945732 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05095792 — Predictive Biomarker (PRD): UBXN11 mRNA
Genes: UBXN11; SOC; UBXD5; PP2243
Study NCT06334315 — Predictive Biomarker (PRD): CYP3A7 mRNA
Genes: CYP3A7
Study NCT05507216 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05861453 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT06465368 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06465368 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06465368 — Predictive Biomarker (PRD): Hormone receptor
Study NCT04997421 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06309797 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT04721691 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study NCT06072430 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05001503 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT05775575 — Predictive Biomarker (PRD): BAK1 mRNA
Genes: BAK1; BAK; BCL2L7; CDN1
Study NCT05775575 — Predictive Biomarker (PRD): BAX mRNA
Genes: BAX; BCL2L4
Study NCT05775575 — Predictive Biomarker (PRD): BAD mRNA
Genes: BAD; BBC6; BCL2L8
Study NCT05775575 — Safety Biomarker (SAF): Cytochrome c
Study NCT05249855 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02589912 — Predictive Biomarker (PRD): NF2 mRNA
Genes: NF2; SCH
Study NCT06429124 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05597761 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06582771 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT05828901 — Predictive Biomarker (PRD): S1PR1 mRNA
Genes: S1PR1; CHEDG1; EDG1
Study NCT06644417 — Monitoring Biomarker (MOI): HBV DNA
Study NCT04968964 — Predictive Biomarker (PRD): TK1 mRNA
Genes: TK1
Study NCT04968964 — Predictive Biomarker (PRD): Hormone receptor
Study NCT05919212 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06383052 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT06508619 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00002238 — Predictive Biomarker (PRD): ARC mRNA
Genes: ARC; KIAA0278
Study NCT06299163 — Predictive Biomarker (PRD): RORA
Genes: RZRA; ROR1; ROR2; ROR3; NR1F1; ROR-alpha; RORalpha; RORa1
Study NCT05726279 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05976932 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study NCT05976932 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT05614336 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT06673199 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT06673199 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT06499948 — Predictive Biomarker (PRD): COL4A3 mRNA
Genes: COL4A3
Study NCT04165486 — Pharmacodynamic Biomarker (PDY): Synuclein alpha
Genes: SNCA; NACP; PARK1
Study NCT05916482 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05071833 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04934228 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05032599 — Predictive Biomarker (PRD): CD5 mRNA
Genes: CD5; LEU1
Study NCT05181631 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT06412198 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT05848375 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06477510 — Surrogate Endpoint (SUR): Probing pocket depth
Study NCT01242046 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05950490 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study NCT05950490 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05950490 — Predictive Biomarker (PRD): IL6
Genes: IL-6; BSF2; HGF; HSF
Study NCT06581692 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT05358249 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT06254326 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study NCT05925972 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT06644456 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study NCT05708235 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05708235 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04213274 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05039736 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT05720273 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT04297761 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT04297761 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05508399 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT04980872 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT05952479 — Predictive Biomarker (PRD): HGS mRNA
Genes: HGS; HRS
Study NCT05952479 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05952479 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05777278 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05777278 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT05777278 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT05777278 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT05492994 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT06671665 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT06694090 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT06689345 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06694363 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT05499169 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT06114550 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT06114550 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT05438810 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05438810 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05577715 — Predictive Biomarker (PRD): Folate receptor alpha
Genes: FOLR1; FOLR
Study NCT06342466 — Surrogate Endpoint (SUR): Hematologic response
Study NCT06235905 — Predictive Biomarker (PRD): SPN mRNA
Genes: SPN; CD43
Study NCT05647382 — Safety Biomarker (SAF): Vascular endothelial cadherin
Genes: CDH5
Study NCT04973293 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT05943795 — Predictive Biomarker (PRD): SI mRNA
Genes: SI
Study NCT03238157 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03238157 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT04895358 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT04895358 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04895358 — Predictive Biomarker (PRD): Hormone receptor
Study NCT04895358 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06009354 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT05304962 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05304962 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05304962 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT05304962 — Predictive Biomarker (PRD): Hormone receptor
Study NCT05304962 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06451770 — Predictive Biomarker (PRD): ANGPTL3 mRNA
Genes: ANGPTL3; ANGPT5; UNQ153/PRO179
Study NCT06451770 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT04220190 — Safety Biomarker (SAF): Th2 cell
Study NCT06007248 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06007248 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT05478824 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Interleukin 13
Genes: IL13; NC30
Study NCT06475599 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT06342960 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05754112 — Predictive Biomarker (PRD): JAK1 mRNA
Genes: JAK1; JAK1A; JAK1B
Study NCT05095623 — Predictive Biomarker (PRD): CFI mRNA
Genes: CFI; IF
Study NCT05358639 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT05358639 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study NCT05358639 — Predictive Biomarker (PRD): PALB2 mRNA
Genes: PALB2; FANCN
Study NCT05656573 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CARTPT mRNA
Genes: CARTPT; CART
Study NCT05656573 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT06368531 — Predictive Biomarker (PRD): REM1 mRNA
Genes: REM1; GES; REM
Study NCT05518799 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT05704036 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT06420076 — Predictive Biomarker (PRD): CD7 mRNA
Genes: CD7
Study NCT06420076 — Predictive Biomarker (PRD): CD5 mRNA
Genes: CD5; LEU1
Study NCT06420076 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT05852717 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT05653752 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05653752 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05653752 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05653752 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05653752 — Predictive Biomarker (PRD): Hormone receptor
Study NCT05112237 — Predictive Biomarker (PRD): MYBPC3 mRNA
Genes: MYBPC3
Study NCT06694688 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06694298 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT06694818 — Predictive Biomarker (PRD): REM1 mRNA
Genes: REM1; GES; REM
Study NCT04579380 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04579380 — Predictive Biomarker (PRD): Hormone receptor
Study NCT05898646 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT05521399 — Predictive Biomarker (PRD): ACR mRNA
Genes: ACR; ACRS
Study NCT05521399 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAV1 mRNA
Genes: CAV1; CAV
Study NCT06631092 — Predictive Biomarker (PRD): NEO1 mRNA
Genes: NEO1; IGDCC2; NGN
Study NCT06631092 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT05861401 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05861401 — Predictive Biomarker (PRD): JAK1 mRNA
Genes: JAK1; JAK1A; JAK1B
Study NCT05861401 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study NCT05861401 — Predictive Biomarker (PRD): JAK3 mRNA
Genes: JAK3
Study NCT05861401 — Predictive Biomarker (PRD): TYK2 mRNA
Genes: TYK2
Study NCT05861401 — Predictive Biomarker (PRD): STAT1 mRNA
Genes: STAT1
Study NCT05861401 — Predictive Biomarker (PRD): STAT2 mRNA
Genes: STAT2
Study NCT05861401 — Pharmacodynamic Biomarker (PDY): Signal transducer and activator of transcription 3
Genes: STAT3; APRF
Study NCT05861401 — Predictive Biomarker (PRD): STAT4 mRNA
Genes: STAT4
Study NCT05861401 — Predictive Biomarker (PRD): JAK1
Genes: JAK1A; JTK3
Study NCT05861401 — Safety Biomarker (SAF): HLA-DRB1
Genes: HLA-DR1B
Study NCT04642261 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT05491447 — Predictive Biomarker (PRD): BMX mRNA
Genes: BMX
Study NCT05623020 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT06317922 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT06430411 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT04739774 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT06367153 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT06367153 — Predictive Biomarker (PRD): CYP2B6 mRNA
Genes: CYP2B6
Study NCT06566196 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT05763862 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT05030441 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study NCT05869604 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05463952 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04681937 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05470712 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT06184763 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT05001165 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT05422222 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT05496231 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05478018 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05478018 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05669703 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06048705 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A